European Society
For Medical Oncology

It is intended for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies

Patients with mental illness significantly more likely to experience premature mortality

The estimates varied substantially by Sociodemographic Index quintile, highlighting global inequities in cancer burden

Findings from a multi-basket MyPathway study

It also approved gallium Ga 68 gozetotide, a radioactive diagnostic agent for PET of PSMA-positive lesions

New indication concerns the treatment of adult patients with previously untreated diffuse large B-cell lymphoma

Efficacy was evaluated using real-world data from the EPIK-P1 study

Findings from the NCI-COG Pediatric MATCH screening Protocol

Evidence for efficacy is based on results from the RELATIVITY-047 study

The ESMO Breast Cancer Congress 2022, the annual event dedicated to advancing the science, disseminating education and improving the practice of breast cancer specialists worldwide, will focus this year on integrating translational research for innovative clinical practice.

A consensus reached by a lung clinical community within the International Cancer Benchmarking Partnership (ICBP), presented at the ELCC, 30 March – 2 April 2022, has highlighted international disparities in management and outcomes of patients with lung cancer in high-income countries, and has provided a roadmap of key actions that should be taken to homogenise practices, help enable earlier diagnosis and offer equitable access to care.  

More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress (ELCC), 30 March-2 April 2022.

The European Lung Cancer Congress 2022 (ELCC), the annual event dedicated to advancing the science, disseminating education and improving the practice of lung cancer specialists worldwide, will be held as a virtual meeting. 

Original data presentations by the authors of the OlympiA and PEARLS/KEYNOTE-091 trials will be followed by critical analysis and discussion with a panel of renowned experts.

ESMO announces a new series of resources designed to guide physicians in areas of oncological practice not covered by guidelines, where current evidence is insufficient to evenly inform clinical decision-making

The ESMO Targeted Anticancer Therapies Congress 2022, designed for basic scientists, physicians and translational researchers belonging to academic settings, industry and regulatory agencies will be held as a virtual meeting.

Open-source approach leveraging ESMO tools can inform sustainable healthcare spending to benefit national populations worldwide

ESMO has announced today that the 2022 ESMO Breast Cancer Award is presented to Sibylle Loibl for her exceptional contribution to clinical research in breast cancer.  

In light of the challenging situation in Prague due to the ongoing arrival of refugees from Ukraine

ESMO expresses profound sadness about the unfolding tragedy in Ukraine and the suffering of people

The 2022 ESMO Heine H. Hansen Award is conferred on Fred R. Hirsch for his lifelong outstanding contribution to lung cancer research

Who will be the next ESMO Awardees? Submit your nominations before 9 March.

Based on current knowledge available, they address key questions on safety and efficacy of COVID-19 vaccines, their interference with anticancer treatment, and advocate for a global strategy for the booster dose 

ESMO President will act as an Advisor

ESMO has announced today that the 2022 ESMO TAT Honorary Award is presented to Lesley K Seymour 

ESMO delivered an official statement at the Special Session of the World Health Assembly to strengthen pandemic prevention, preparedness and response